# Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver Metastasis

> **NCT02345746** · PHASE2 · WITHDRAWN · sponsor: **Western Regional Medical Center**

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Folinic Acid
- **DRUG:** 5-Fluorouracil

## Key facts

- **NCT ID:** NCT02345746
- **Lead sponsor:** Western Regional Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-12
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** patient population
- **Last updated:** 2017-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02345746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02345746, "Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver Metastasis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02345746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*